Sort   by:  
 Page size 
Men who develop metastatic castration-resistant prostate cancer (CRPC) invariably succumb to the disease. The development and progression to CRPC following androgen ablation therapy is predominantly driven by unregulated androgen receptor (AR) signaling1-3. Despite the success of recently approved...
ORGANISM(S): Homo sapiens 
Sort   by:  
 Page size